<DOC>
	<DOCNO>NCT01785615</DOCNO>
	<brief_summary>Little know regard association individual component metabolic syndrome ( MBS ) prothrombotic , inflammatory preclinical cardiac structural functional marker woman syndrome . Less known adequate treatment pathological mechanism syndrome well understood . The purpose study two fold ; 1 . To determine basic difference biochemical cardiovascular structural marker woman without MBS association individual component MBS . 2 . To determine impact atorvastatin low risk factor Metabolic Syndrome . Atorvastatin one effective drug approve United States Food Drug Administration ( FDA ) treatment high cholesterol . It belong class drug call statin role primary prevention still unclear . Thus population seem ideal group may benefit intervention .</brief_summary>
	<brief_title>Prothrombotic Inflammatory Markers Women With Metabolic Syndrome - Effect Atorvastatin</brief_title>
	<detailed_description>The first phase study observational phase previously describe . The second phase prospective evaluation effect well know `` statin '' drug ( Liptor ) different biochemical factor measure blood . The eligible study participant blood work do upon enrollment criterion meet ( accord Adult Treatment Panel III ) , give dietary counseling ( NYHA - New York Heart Association Step 1 diet ) lead phase . Lab work repeat 3 week evaluate impact diet participant 's profile still meet criterion MBS , randomization either atorvastatin ( Liptor ) 80mg placebo ( sugar pill ) 12 week take place .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Women age 1875 Metabolic syndrome Abdominal circumference &gt; 35 Hypertriglyceridemia &gt; 150mg/dl HDL &lt; 50 Blood Pressure &gt; 130/85 Fasting Glucose &gt; 100 Pregnant planning become pregnant next 612 month Receiving lipidlowing drug Obstructive hepatobiliary disease serious hepatic disease Diabetes , cardiovascular disease ( CVD ) , hypothyroidism , active infection , cancer , recent surgery Fulfill criterion receive statin base LDL level , risk factor , Framingham risk score outline ATP111/NCEP 111 recommendation Documented allergic reaction statin past unexplained elevation creatinine kinase level &gt; 3 time upper limit</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>metabolic syndrome</keyword>
	<keyword>atorvastatin</keyword>
	<keyword>woman</keyword>
</DOC>